MDX LIFESCIENCES, Inc. is a clinical stage biotechnology company developing

autologous transplantation for tissue and organ regeneration.


Our development programs are primarily focused Myocardial Ischemia, reperfusion injury and neurodegenerative & neuromuscular diseases including: Huntington’s Disease, Multiple Sclerosis/Optic Neuritis, Wolfram Syndrome, Epilepsy, Traumatic Brain Injury (TBI), Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, and Parkinson Disease. On-going research has linked these diseases to various malfunctions of the mitochondria. MDX LIFESCIENCES, Inc. aims at opening the way for a broad range of disease modifying therapies for tissue regeneration and achieving clear clinical end points to monitor the various therapies.